Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.6101
Nov 16 • 3:59 PM ET Dollar change-0.0192 Percentage change(-3.05%)
Aftermarket Close
0.6101
Aftermarket • 5:00 PM ET Dollar change0.0000 Percentage change(0.00%)
Index
RUT
Market Cap
64.79M
Enterprise Value
40.23M
Income
-29.81M
Sales
19.06M
Book/sh
0.30
Cash/sh
0.36
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
102
IPO
Jan 27, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
3.40
P/B
2.04
P/C
1.68
P/FCF
-
EV/EBITDA
-
EV/Sales
2.11
Quick Ratio
4.50
Current Ratio
5.10
Debt/Eq
0.44
LT Debt/Eq
0.43
Option/Short
Yes / Yes
EPS (ttm)
-0.30
EPS next Y
-0.30
EPS next Q
-0.08
EPS this Y
24.42%
EPS next Y
8.72%
EPS next 5Y
16.54%
EPS past 3/5Y
25.18% 14.09%
Sales past 3/5Y
25.79% 115.18%
EPS Y/Y TTM
42.64%
Sales Y/Y TTM
79.96%
EPS Q/Q
59.54%
Sales Q/Q
73.41%
Insider Own
19.86%
Insider Trans
-0.13%
Inst Own
17.79%
Inst Trans
13.87%
ROA
-60.05%
ROE
-101.73%
ROIC
-65.66%
Gross Margin
52.65%
Oper. Margin
-167.64%
Profit Margin
-156.42%
SMA20
-14.55%
SMA50
-21.68%
SMA200
-44.61%
Trades
Shs Outstand
91.14M
Shs Float
85.10M
52W High
1.93 -68.47%
52W Low
0.61 -0.08%
Volatility
7.34% 7.14%
ATR (14)
0.05
RSI (14)
34.00
Beta
1.51
Rel Volume
0.67
Avg Volume
737.52K
Volume
497,704
Perf Week
-13.68%
Perf Month
-19.17%
Perf Quarter
-31.89%
Perf Half Y
-57.92%
Perf YTD
-37.70%
Perf Year
-46.95%
Perf 3Y
-53.07%
Perf 5Y
-93.87%
Perf 10Y
-
Prev Close
0.63
Price
0.61
Change %
-3.05%
Consensus
Strong Buy
Avg. Price Target
$2.02
Implied Upside
+231.1%
Analysts3incl. previous ratings
Rating Distribution2 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Apr 29, 2026Initiated
BBTIG Research
Buy$2+227.8%
Aug 11, 2022Downgrade
WFC logoWWells Fargo
Overweight → Equal Weight$8 → $2.40+293.4%
May 31, 2022Initiated
EVR logoEEvercore ISI
Outperform$7+1,047.4%
Apr 14, 2022Initiated
WFC logoWWells Fargo
Overweight$8+1,211.3%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TEISSEYRE THOMASChief Operating OfficerAug 24 '26Sale0.857,3456,273671,256Aug 25 04:15 PM
HALE BRETTCFO and CAOAug 24 '26Sale0.857,3456,273592,420Aug 25 04:14 PM
HALE BRETTCFO and CAOMay 26 '26Sale1.656,0479,978599,765May 27 04:26 PM
TEISSEYRE THOMASChief Operating OfficerMay 26 '26Sale1.656,0479,978678,601May 27 04:26 PM
TEISSEYRE THOMASChief Operating OfficerMar 23 '26Sale1.2124,18829,267354,648Mar 25 05:15 PM
HALE BRETTCFO and CAOMar 23 '26Sale1.2124,18829,267275,812Mar 25 05:14 PM
TEISSEYRE THOMASChief Operating OfficerFeb 13 '26Sale1.11821913378,836Feb 17 03:39 PM
TEISSEYRE THOMASChief Operating OfficerNov 19 '25Sale1.081,4051,517379,657Nov 19 07:07 PM
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M. Rothberg and Ronald Walsworth on February 25, 2014 and is headquartered in Guilford, CT.
CEOMs. Maria Degois-Sainz
Founder & Vice ChairmanDr. Jonathan M. Rothberg Ph.D.
Chief Administrative OfficerMr. Brett Hale
Chief Operating OfficerDr. Thomas Teisseyre Ph.D.
Vice President of TechnologyRafael O'Halloran